| BA. | 16-Feb-26 |
Transfer From |
Charles Woodburn |
0.000p | 3 |
£0.00 |
| BA. | 16-Feb-26 |
Buy |
Charles Woodburn |
2,027.80p | 8 |
£162.22 |
| BA. | 16-Feb-26 |
Transfer From |
Brad Greve |
0.000p | 3 |
£0.00 |
| BA. | 16-Feb-26 |
Buy |
Brad Greve |
2,027.80p | 7 |
£141.95 |
| GSK | 13-Feb-26 |
Sell |
Luke Miels |
2,160.02p | 15,579 |
£336,509.53 |
| GSK | 13-Feb-26 |
Sell |
Luke Miels |
2,160.02p | 15,579 |
£336,509.53 |
| SGE | 12-Feb-26 |
Buy |
John Bates |
810.97p | 35,000 |
£283,839.51 |
| SGE | 12-Feb-26 |
Buy Dividends |
Steve Hare |
811.49p | 11,422 |
£92,688.38 |
| BA. | 16-Feb-26 |
Buy |
Charles Woodburn |
2,027.80p | 8 |
£162.22 |
| BA. | 16-Feb-26 |
Buy |
Brad Greve |
2,027.80p | 7 |
£141.95 |
| BA. |
2,110.00p |
+4.0% |
| QQ. |
517.00p |
+3.7% |
| APTD |
241.00p |
+2.6% |
| CCC |
3,032.00p |
+2.2% |
| FLTR |
9,416.00p |
+2.2% |
| GNS |
3,130.00p |
+1.8% |
| OXIG |
2,645.00p |
+1.3% |
| SN. |
1,334.00p |
+1.3% |
| GSK |
2,268.00p |
+1.3% |
| XPP |
1,390.00p |
+1.0% |
| BT.A |
203.30p |
-2.4% |
| BVC |
13.78p |
-1.8% |
| NCC |
135.80p |
-0.0% |
Top of Page
You are here:
research